North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
|Articles|May 1, 1996
Supplements and Featured Publications
- Shifting Paradigms in the Treatment of Acid-Related Disorders
- Volume 2
- Issue 7 Suppl
Introduction
Author(s)Lawrence J. Brandt, MD
Advertisement
Articles in this issue
over 30 years ago
Reflux Esophagitis/GERDover 30 years ago
Duodenal/Gastric Ulcerover 30 years ago
Analysis: PPIs and H2RAsover 30 years ago
Interviewover 30 years ago
Selected Abstractsover 30 years ago
CME Quizover 30 years ago
Gastroesophageal Diseaseover 30 years ago
Goals and Objectivesover 30 years ago
Participating FacultyAdvertisement
Related to this article
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A follicular lymphoma survivor shares axi-cel CAR T-cell therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improve quality of life.
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
Advertisement
Advertisement
Trending on AJMC
1
Tavapadon for Parkinson Disease Approved by FDA
2
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
3
DME Drug Remigromig Hits Primary End Point in Phase 3 Trial
4
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
5